Orthofix Gains FDA Clearance of G-Beam Fusion Beaming System

By Julie A. Vetalice

Orthofix received FDA 510(k) clearance to market the G-Beam™ Fusion Beaming system, designed to provide alignment, stabilization and fixation to treat neuropathic deformities such as Charcot foot.

G-Beam is accompanied by single-use, sterile-packed implants and a compact instrumentation tray. The system supports the company's strategy to be a premium provider for Charcot and diabetic foot markets.

Source: Orthofix International N.V.
Orthofix G-Beam Fusion Beaming System

Image courtesy of Orthofix International N.V.

Product Labels: Trauma Ankle/Foot/Toe

Tags: 510(k) Clearance, Regulatory